State of the Art: The Role of Inflammation and Dyslipidemia on Cardiovascular Risk in Patients with Renal Dysfunction
George A. Kaysen
Figure 3. Inflammation and dyslipidemia in patients with kidney disease are associated with subsequent altered vascular structure and an increased risk of CV events.
